Silver Book Fact

A one percent reduction in lung, colorectal, breast, leukemia, pancreatic, and brain cancer mortality would reduce productivity costs by $814 million per year.

Bradley, C, K Yabroff, B Dahman, E Feuer, A Mariotto, et al. Productivity Costs of Cancer Mortality in the United States: 2000-2020. J Natl Cancer Inst. 2008; 100(24): 1763-70. http://www.ncbi.nlm.nih.gov/pubmed/19066273

Reference

Title
Productivity Costs of Cancer Mortality in the United States: 2000-2020
Publication
J Natl Cancer Inst
Publication Date
2008
Authors
Bradley, C, K Yabroff, B Dahman, E Feuer, A Mariotto, et al.
Volume & Issue
Volume 100, Issue 24
Pages
1763-70
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, a medicine to fight breast cancer is currently in the pipeline. It targets the Bcl-2 protein, which appears to contribute…  
  • A modest decrease of 1% in cancer mortality has been estimated to be worth $500 billion in social value.  
  • Percentage of women age 50 and over who had a mammogram in the past 2 years, by age group, selected years 1987-2005  
  • The overall five-year survival rate for men with prostate cancer is 99 percent—up from 43 percent in 1975.  
  • The use of imatinib (Gleevec) has increased the eight-year survival rate for early chronic-phase myelogenous leukemia from 65% to 84%.